Overview

The Effect of Intravitral Injection of Triamcinolone Combined With Cataract Surgery (Phacoemulsification) on Diabetic Macular Edema and Diabetic Retinopathy

Status:
Unknown status
Trial end date:
2009-04-01
Target enrollment:
0
Participant gender:
All
Summary
In this study, regressed proliferative diabetic retinopathy, very severe, severe and moderate non-prolifrative diabetic retinopathy patients who were going to have a cataract surgery, underwent a complete eye examination, OCT, FAG and color photography 2 weeks prior to their operation. All patients divided in two: 1) control group (Phyco,PCIOL), 2) triamcinolone treatment group (Phaco with PCIOL+IVT). One month after surgery a complete eye examination will be done especially; IOP and endophthalmitis. A 6 month follow-up will be done for these two groups and diabetic retinopathy progression will be checked.
Phase:
Phase 1/Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Shahid Beheshti University of Medical Sciences
Treatments:
Triamcinolone
Triamcinolone Acetonide
Triamcinolone diacetate
Triamcinolone hexacetonide
Criteria
Inclusion Criteria:

- Diabetic patients with non-proliferative diabetic retinopathy and regressed PDR

Exclusion Criteria:

- Uncontrolled HTN

- History of glaucoma

- Active PDR

- NVI

- TRD

- Any ophthalmic operation

- Renal problem(cr>3)

- CVA

- Uveitis